Lv1
46 积分 2024-07-15 加入
IFNα2b modulates anti-tumor immune responses involving STAT3-associated dendritic cell dysfunction in JAK2v617f-positive myeloproliferative neoplasms
8天前
已完结
Loss of Dnmt3a increases self-renewal and resistance to pegIFN-α in JAK2-V617F-positive myeloproliferative neoplasms
18天前
已完结
Immunotherapeutic targeting of calreticulin mutant myeloproliferative neoplasms
18天前
已完结
A first-in-class JAK/ROCK inhibitor, Rovadicitinib in patients with myelofibrosis who were refractory or relapsed or intolerant to Ruxolitinib: A single-arm, multicenter, open-label, phase Ib study
18天前
已完结
Spatial profiling of the spleen in mouse and human myelofibrosis reveals complement-driven immune-stromal interactions as a therapeutic target
18天前
已完结
IFNα2b modulates anti-tumor immune responses involving STAT3-associated dendritic cell dysfunction in JAK2v617f-positive myeloproliferative neoplasms
18天前
已完结
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
1个月前
已完结
The role of JAK/STAT signaling pathway and its inhibitors in diseases
1个月前
已完结
Continuous IV infusion of MESNA can prevent hemorrhagic cystitis in HSCT and retain MESNA concentration in urine
1个月前
已完结
A first-in-class JAK/ROCK inhibitor, rovadicitinib, for glucocorticoid-refractory or -dependent chronic GVHD
1个月前
已完结
皖公网安备34019202002308
